SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Heart (CAMH)-What is this???
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (17)3/19/1997 11:56:00 PM
From: James Perry   of 33
 
Thanks John. I can't really feel very enlightened by the CAMH press release. Not intentionally bad mouthing a stock I own, you understand, but it seems to me that if this were truly an important test that a little more description would have been given. Or maybe they will just need a lot more data before they can make an effective presentation to FDA.
I talked to Bennett about MABXA, which has fallen quite a bit. He seemed to feel that the market was giving greater credit to the competition than it really deserved. I said that poorly. He did not put down the competitive treatment, but simply felt that in the treatment of a person both would be needed, so that they were not really competitive. In short, it still would be necessary to dx and locate the presence of a clot. If you concur, then perhaps we should be picking up more of this.
If you look over on Igen, you might want to add a bit to a message I left there recently.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News